Welcome to OrbiMed! We appreciate your interest in our firm and investment funds.

The worldwide life sciences industry has come of age in many measurable ways, including the number of compounds in human testing, the number of approved products and the number of profitable companies.

Fueled by rising global affluence and increasing demand for new and better drugs from the aging "baby boomer" generation, the health sciences industry has responded with increased innovation and greater investment in research and development.

For investors, the next decade should provide many attractive opportunities to participate in the growth of this industry. If you would like to learn more about our investment funds, please click on your area of interest: hedge funds, private equity funds, or mutual funds.